Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junran Zhang

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Nature|December 17, 2010
H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytesBeth A Helmink, Anthony T Tubbs, Yair Dorsett, et al.
Elife|October 4, 2024
Inhibition of <i>O</i>-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathwayJianwen Chen, Bao Zhao, Hong Dong, et al.
Theranostics|October 24, 2022
ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transitionShurui Cai, Na Li, Xuetao Bai, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Inhibition of <i>O</i>-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathwayJianwen Chen, Bao Zhao, Hong Dong, et al.
Cell Reports. Medicine|January 10, 2025
Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growthOhuod Hawsawi, Weinan Xue, Tingting Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2018
RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer CellsXiaosong Yang, You Pan, Zhaojun Qiu, et al.
Journal of Cellular and Molecular Medicine|October 13, 2025
BNIP3L/BNIP3-Mediated Mitophagy Contributes to the Maintenance of Ovarian Cancer Stem CellsNa Li, Tejinder Pal Khaket, Yajing Yang, et al.
Molecular Cancer Therapeutics|September 20, 2019
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2<sup>-/-</sup> Ovarian Cancer CellsLu Liu, Shurui Cai, Chunhua Han, et al.
JCI Insight|May 17, 2022
Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatmentSydney Stern, Dongdong Liang, Linhao Li, et al.
Research Square|May 19, 2023
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activityChandra Bhushan Prasad, Adrian Oo, Zhaojun Qiu, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Nature|December 17, 2010
H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytesBeth A Helmink, Anthony T Tubbs, Yair Dorsett, et al.
Elife|October 4, 2024
Inhibition of <i>O</i>-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathwayJianwen Chen, Bao Zhao, Hong Dong, et al.
Theranostics|October 24, 2022
ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transitionShurui Cai, Na Li, Xuetao Bai, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Inhibition of <i>O</i>-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathwayJianwen Chen, Bao Zhao, Hong Dong, et al.
Cell Reports. Medicine|January 10, 2025
Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growthOhuod Hawsawi, Weinan Xue, Tingting Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2018
RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer CellsXiaosong Yang, You Pan, Zhaojun Qiu, et al.
Journal of Cellular and Molecular Medicine|October 13, 2025
BNIP3L/BNIP3-Mediated Mitophagy Contributes to the Maintenance of Ovarian Cancer Stem CellsNa Li, Tejinder Pal Khaket, Yajing Yang, et al.
Molecular Cancer Therapeutics|September 20, 2019
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2<sup>-/-</sup> Ovarian Cancer CellsLu Liu, Shurui Cai, Chunhua Han, et al.
JCI Insight|May 17, 2022
Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatmentSydney Stern, Dongdong Liang, Linhao Li, et al.
Research Square|May 19, 2023
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activityChandra Bhushan Prasad, Adrian Oo, Zhaojun Qiu, et al.
Pageof 13